| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |